New asthma inhaler version tested in kids: same drug, different delivery
NCT ID NCT07433569
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two versions of the asthma inhaler Symbicort (budesonide/formoterol) in children aged 4 to 12 with asthma. The goal is to see how much of the drug gets into the blood with each version and whether they are safe. Fifteen children will take single doses of both the new Aerosphere and the standard pMDI inhaler. The results will help doctors understand if the new version works similarly in kids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
budesonide and formoterol (combination inhaler)
What this could lead to
If successful, this could show that a new inhaler version delivers the same asthma control with similar drug levels in children, offering an alternative treatment option.
What could go wrong
This is a very early (Phase 1) study with only 15 children, so results may not apply broadly. It focuses on drug levels in the blood, not on how well asthma symptoms are controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Long Beach, California, 90815, United States
-
Research Site
Miami, Florida, 33175, United States
-
Research Site
Lafayette, Louisiana, 70508, United States
-
Research Site
Toledo, Ohio, 43617, United States
-
Research Site
Boerne, Texas, 78006, United States
-
Research Site
El Paso, Texas, 79903, United States